Literature DB >> 16038042

Expression of c-erbB-2 and glutathione S-transferase-pi in hepatocellular carcinoma and its adjacent tissue.

Zhao-Shan Niu1, Mei Wang.   

Abstract

AIM: To investigate the possible role of c-erbB-2 and glutathione S-transferase (GST-Pi) in primary hepatocellular carcinogenesis and the relationship between liver hype-rplastic nodule (LHN), liver cirrhosis (LC), and hepatocellular carcinoma (HCC).
METHODS: The expression of c-erbB-2 and GST-Pi was detected immunohistochemically in 41 tissue specimens of HCC and 77 specimens of its adjacent tissue.
RESULTS: The positive expression of c-erbB-2 in LHN (28.6%) was significantly higher than that in LC (0%) (P = 0.032<0.05), but no significant difference was seen between HCC and LHN or LC (P>0.05, chi2= 0.002, 3.447). The positive expression of GST-Pi in HCC (89.6%) or LHN (71.1%) was significantly higher than that in LC (22.9%, P<0.001, chi2= 49.91, 16.96). There was a significant difference between HCC and LHN (P<0.05, chi2= 6.353).
CONCLUSION: The c-erbB-2 expression is an early event in the pathogenesis of HCC. GST-Pi may be a marker enzyme for immunohistochemical detection of human HCC and its preneoplastic lesions. LHN seems to be a preneoplastic lesion related to hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038042      PMCID: PMC4434670          DOI: 10.3748/wjg.v11.i28.4404

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  [Expression of rasp21, C-myc, C-erbB-2, and AFP in 2-FAA induced experimental hepatocarcinogenesis].

Authors:  G Shi; C Sun; X Han; X Meng; M Wang; M Gu
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2001-04

2.  Expression of glutathione s-transferase pi in benign mucosa, Barrett's metaplasia, and adenocarcinoma of the esophagus.

Authors:  Rakesh K Chandra; Brandon G Bentz; G Kenneth Haines; Alan M Robinson; James A Radosevich
Journal:  Head Neck       Date:  2002-06       Impact factor: 3.147

3.  EGFR and ErbB2 differentially regulate Raf-1 translocation and activation.

Authors:  Lianfeng Zhang; Mary Bewick; Robert M Lafrenie
Journal:  Lab Invest       Date:  2002-01       Impact factor: 5.662

Review 4.  The role of overexpressed HER2 in transformation.

Authors:  R M Neve; H A Lane; N E Hynes
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

5.  Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells.

Authors:  Jila Bakker; Xiaohui Lin; William G Nelson
Journal:  J Biol Chem       Date:  2002-04-17       Impact factor: 5.157

6.  Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis.

Authors:  K Miyanishi; T Takayama; M Ohi; T Hayashi; A Nobuoka; T Nakajima; R Takimoto; K Kogawa; J Kato; S Sakamaki; Y Niitsu
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

7.  Glutathione S-transferase P1 has protective effects on cell viability against camptothecin.

Authors:  Takamitsu Hara; Takeo Ishii; Mina Fujishiro; Michiaki Masuda; Takaaki Ito; Jun Nakajima; Tomio Inoue; Takeshi Matsuse
Journal:  Cancer Lett       Date:  2004-01-20       Impact factor: 8.679

8.  Anomalous elevation of glutathione S-transferase P-form (GST-P) in the elementary process of epigenetic initiation of chemical hepatocarcinogenesis in rats.

Authors:  Kimihiko Satoh; Ichiro Hatayama
Journal:  Carcinogenesis       Date:  2002-07       Impact factor: 4.944

Review 9.  Dysregulation of cellular signaling by HER2/neu in breast cancer.

Authors:  Binhua P Zhou; Mien-Chie Hung
Journal:  Semin Oncol       Date:  2003-10       Impact factor: 4.929

10.  Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs.

Authors:  Shinji Goto; Kensaku Kamada; Yoko Soh; Yoshito Ihara; Takahito Kondo
Journal:  Jpn J Cancer Res       Date:  2002-09
View more
  9 in total

1.  Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools.

Authors:  Emelyne Dejeux; Virginie Audard; Catherine Cavard; Ivo Glynne Gut; Benoit Terris; Jörg Tost
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

2.  Effect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma risk.

Authors:  Chao Ou; Hai-Ping Zheng; Jian-Jia Su; Ji Cao; Guo-Jian Li; Le-Qun Li
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

Review 3.  Chronic hepatitis B in hepatocarcinogenesis.

Authors:  N H Park; I H Song; Y-H Chung
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

4.  Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.

Authors:  Neung Hwa Park; Il Han Song; Young-Hwa Chung
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

5.  Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma.

Authors:  Yao-Li Chen; Hsin-Shun Tseng; Wu-Hsien Kuo; Shun-Fa Yang; Dar-Ren Chen; Hsiu-Ting Tsai
Journal:  BMC Med Genet       Date:  2010-03-24       Impact factor: 2.103

6.  Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer.

Authors:  Jie Liu; Angela Ahiekpor; Li Li; Xianxing Li; Patrick Arbuthnot; Michael Kew; Mark A Feitelson
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

7.  The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma.

Authors:  Nuray Bassullu; Ilknur Turkmen; Murat Dayangac; Pinar Yagiz Korkmaz; Reyhan Yasar; Murat Akyildiz; Onur Yaprak; Yaman Tokat; Yildiray Yuzer; Gulen Bulbul Dogusoy
Journal:  Hepat Mon       Date:  2012-10-11       Impact factor: 0.660

8.  Hepatitis B virus X upregulates HuR protein level to stabilize HER2 expression in hepatocellular carcinoma cells.

Authors:  Chao-Ming Hung; Wei-Chien Huang; Hsiao-Lin Pan; Pei-Hsuan Chien; Chih-Wen Lin; Lei-Chin Chen; Yu-Fong Chien; Ching-Chiao Lin; Kar-Hee Leow; Wen-Shu Chen; Jhen-Yu Chen; Chien-Yi Ho; Pao-Sheng Hou; Yun-Ju Chen
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411

9.  The potential value of CDV3 in the prognosis evaluation in Hepatocellular carcinoma.

Authors:  Heng Xiao; Baoyong Zhou; Ning Jiang; Yunshi Cai; Xiongwei Liu; Zhengrong Shi; Ming Li; Chengyou Du
Journal:  Genes Dis       Date:  2018-01-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.